CN1562120A - Medicine for treating nasosinusitis - Google Patents

Medicine for treating nasosinusitis Download PDF

Info

Publication number
CN1562120A
CN1562120A CN 200410012237 CN200410012237A CN1562120A CN 1562120 A CN1562120 A CN 1562120A CN 200410012237 CN200410012237 CN 200410012237 CN 200410012237 A CN200410012237 A CN 200410012237A CN 1562120 A CN1562120 A CN 1562120A
Authority
CN
China
Prior art keywords
gram
treatment
grams
medicine
bushicao
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200410012237
Other languages
Chinese (zh)
Other versions
CN1225281C (en
Inventor
赵开峰
景珍平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410012237 priority Critical patent/CN1225281C/en
Publication of CN1562120A publication Critical patent/CN1562120A/en
Application granted granted Critical
Publication of CN1225281C publication Critical patent/CN1225281C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine for treating nasosinusitis is prepared from 10 Chinese-medicinal materials including astragalus root, peach kernel, asarum herb, Chuan-xiong rhizome, etc.

Description

A kind of medicine for the treatment of sinusitis
Technical field
The present invention relates to a kind of medicine for the treatment of sinusitis, belong to technical field of Chinese medicines.
Background technology
Nasal sinuses is the general name of gassiness bone cavity around the nasal cavity, has 4 pairs, comprises maxillary sinus, sinus frontalis, sieve hole and sphenoid sinus.The hole chamber of pressing the anatomical features maxillary sinus is bigger, the very little position of opening height, and drain is poor, the sickness rate height.But the therapeutic effect of existing medicine is not good, as the bidouyan mixture, bidouyan koufuye that commercially available Tong Junge pharmaceutical factory, Tai Ji group Chongqing produces, its course of treatment long (20 days is a course of treatment), clinically be recommended as 2-3 the course of treatment, medical expense is higher, is lower than medicament provided by the present invention through clinical comparison test obvious effective rate.
Summary of the invention
The invention provides a kind of short treating period, evident in efficacy, medical expense is low, is difficult for the medicine of the pure treatment by Chinese herbs sinusitis of recurrence.
The present invention adopts following scheme to realize, the medicine of treatment sinusitis is characterized in that it is the medicament of being made by the raw material of following weight ratio:
Radix Astragali 10-30 gram cowherb BUSHICAO 6-15 gram Semen Persicae 6-15 gram
The thin 5-10 gram of Flos Magnoliae 6-15 gram Fructus Xanthii 6-15 gram stone Chang
Herba Asari 2-6 gram Rhizoma Chuanxiong 5-15 gram Herba Houttuyniae 3-15 gram Radix Platycodonis 5-10 gram.
The present invention is a kind of medicine for the treatment of sinusitis, and wherein the weight proportion of each raw material is:
Radix Astragali 12-20 gram cowherb BUSHICAO 7-12 gram Semen Persicae 7-12 gram
The thin 7-10 gram of Flos Magnoliae 7-10 gram Fructus Xanthii 7-10 gram stone Chang
Herba Asari 2-4 gram Rhizoma Chuanxiong 7-10 gram Herba Houttuyniae 6-10 gram Radix Platycodonis 6-8 gram.
The present invention is for making curative effect better, and the weight proportion of preferred following raw materials according is:
The Radix Astragali 15 gram cowherb BUSHICAO 10 gram Semen Persicaes 10 grams
Thin 6 grams of Flos Magnoliae 9 gram Fructus Xanthii, 9 gram stone Chang
Herba Asari 3 gram Rhizoma Chuanxiongs 6 gram Herba Houttuyniae 10 gram Radix Platycodoniss 6 grams.
The present invention according to Chinese medicine monarch, minister, help, make and carry out compatibility, monarch drug Radix Astragali benefiting QI for strengthening the superficies in the side, the expelling the toxic substance from the body with tonic skin infection, ingredient L-3 hydroxyl-9-first chlorine stem Lignum pterocarpi indici have antibacterial action, can human body immunity improving power; The Semen Persicae promoting blood circulation to remove blood stasis, contained catechu have vasoconstrictive, reduces the effect of oozing out; The cowherb BUSHICAO can clearing the nasal passage, reaches the sensible effect of QI invigorating detumescence; Contained eugenol in the Flos Magnoliae can play convergence, protection mucosal surface, improves the effect of local circulation; The Fructus Xanthii pain relieving of can detoxifying, eliminating stagnation is sensible, and staphylococcus and bacillus are all had inhibitory action; Thin and the Herba Asari of stone Chang can loose heresy, dry, pain relieving, antihistaminic and the reflection of resistance attitude; Rhizoma Chuanxiong has promoting blood circulation and stopping pain, improves the nose circulation, reduces edema secretions, the effect of anti-proliferation of fibrous tissue; Herba Houttuyniae can detoxify, thereby strengthens the peripheral leukocytic phagocytic activity of human body, human body immunity improving power; The smooth hole antiallergic of Radix Platycodonis evacuation of pus has strengthening vital QI to eliminate pathogenic factors, the effect for the treatment of both the principal and secondary aspects of a disease.
The method for preparing medicine of the present invention:
1, takes by weighing raw material by above-mentioned weight proportion.
2, removal of contamination is used the non-metallic vessel splendid attire.
3, room temperature rinsing 2-3 time.
4, the Radix Astragali, Semen Persicae, cowherb BUSHICAO, stone Chang is thin, Herba Houttuyniae mixes and decocts, and one time 40 minutes, be concentrated to 100-200ml after three times, be mixed in the making sheet and dry naturally with the Flos Magnoliae of pulverizing, Fructus Xanthii, Herba Asari, Rhizoma Chuanxiong, Radix Platycodonis raw material.
5, dry the back and mix pulverizing with Chinese medicine grinder.
6, sieve with 120 orders, incapsulate.
The present invention is as follows through the clinical comparison result of the test:
The treatment group is chosen 130 routine patients and is taken two courses of treatment of medicine of the present invention (the clear relieving capsule of nose) treatment, 10 days each courses of treatment, cure 50 examples (38.46%), produce effects 57 examples (43.85%), effective 16 examples (12.31%), invalid 7 examples (5.38%), total obvious effective rate reaches 82.31%, and total effective rate reaches 94.62%.Each symptom treatment front and back integration situation of change is organized in treatment, sees Table 1.The result shows that treatment each symptom integral of back and total mark value are all than the decline (P<0.001) that highly significant is arranged before the treatment.
Table 1: each symptom integral variation before and after the treatment of treatment group (X ± S)
Symptom The example number Before the treatment After the treatment The P value
Nose is cold ????128 ?2.73±0.63 ?0.53±0.65 ????<0.001
Headache ????102 ?1.82±0.65 ?0.54±0.62 ????<0.001
The pus nasal mucus ????92 ?1.63±0.61 ?0.42±0.54 ????<0.001
Hyposmia ????84 ?1.57±0.66 ?0.32±0.56 ????<0.001
Lassitude ????52 ?1.54±0.5 ?0.12±0.32 ????<0.001
Total mark ????130 ?7.03±2.37 ?0.69±0.70 ????<0.001
Matched group is chosen 110 routine patients and is taken medicine of the present invention (the clear relieving capsule of nose), each 2, every day three times, 20 days each courses of treatment, cure 30 examples (27.27%), produce effects 49 examples (44.55%), effective 20 examples (18.18%), invalid 11 examples (10.0%), total obvious effective rate 71.82%, total effective rate reaches 90.00%.Integration situation of change before and after each symptom treatment of matched group sees Table 2.The result shows that treatment each symptom integral of back and total mark value are all than before the treatment significant decline (P<0.001) being arranged.
Table 2: each symptom integral variation before and after the treatment of control group (X ± S)
Symptom The example number Before the treatment After the treatment The P value
Nose is cold ????107 ?2.26±0.63 ??0.67±0.71 ????<0.001
Headache ????93 ?2.00±0.66 ??0.67±0.70 ????<0.001
The pus nasal mucus ????88 ?1.63±0.63 ??0.66±0.62 ????<0.001
Hyposmia ????67 ?1.54±0.68 ??0.33±0.59 ????<0.001
Lassitude ????40 ?1.40±0.59 ??0.15±0.43 ????<0.001
Total mark ????110 ?7.26±2.80 ??2.24±2.06 ????<0.001
Treatment group and matched group general curative effect relatively see Table 3.
Table 3: treatment group and matched group general curative effect are relatively
Group The example number Cure Produce effects Effectively Invalid Total obvious effective rate (%) Total effective rate (%)
The treatment group 130 50 57 16 7 82.31 94.62
Matched group 110 30 49 20 11 71.82 90.00
Each symptom integral difference relatively sees Table 4 before and after treatment group and the treatment of control group.The result shows that the improvement of symptoms such as the treatment group is cold to nose, headache is better than matched group.
Table 4: each symptom integral difference comparison before and after two groups of treatments (X ± S)
Symptom The treatment group Matched group The P value
The example number Difference The example number Difference
Nose is cold ??128 ?1.84±0.78 ????107 ?1.59±0.80 ?<0.05
Headache ??102 ?1.29±0.75 ????93 ?1.42±0.84 ?<0.05
The pus nasal mucus ??92 ?1.21±0.75 ????88 ?0.97±0.88 ?<0.05
Hyposmia ??84 ?1.25±0.67 ????67 ?1.21±0.75 ?<0.05
Lassitude ??52 ?1.44±0.54 ????40 ?1.27±0.55 ?<0.05
Total mark ??130 ?5.34±2.54 ????110 ?5.02±2.97 ?<0.05
The criterion of above curative effect is: adopt the percentage ratio of sxemiquantitative integration method statistics treatment front and back symptom, sign to change, be divided into level Four.In two courses of treatment, cure: treatment back clinical symptoms, sign disappear, and integration is reduced to " 0 "; Produce effects: treatment back clinical symptoms, sign disappear substantially, and the integration total value reduces 〉=80%; Effectively: treatment back clinical symptoms, sign are improved, and the integration total value reduces 〉=30%, but less than 60%; Invalid: treatment back clinical symptoms, sign do not have significant change, and the integration total value reduces<30%.
The specific embodiment
Embodiment 1
1, press column weight amount proportioning and take by weighing raw material:
The Radix Astragali 15 grams, cowherb BUSHICAO 10 grams, Semen Persicae 10 grams, Flos Magnoliae 9 grams, Fructus Xanthii 9 grams, thin 6 grams of stone Chang, Herba Asari 3 grams, Rhizoma Chuanxiong 6 grams, Herba Houttuyniae 10 grams, Radix Platycodonis 6 grams.
2, removal of contamination is used the non-metallic vessel splendid attire.
3, room temperature rinsing 2-3 time.
4, the Radix Astragali, Semen Persicae, cowherb BUSHICAO, stone Chang is thin, Herba Houttuyniae mixes and boils, and each 40 minutes, be concentrated to 100-200ml after three times, merge medicinal liquid, be mixed in the making sheet and dry naturally with the Flos Magnoliae of pulverizing, Fructus Xanthii, Herba Asari, Rhizoma Chuanxiong, Radix Platycodonis raw material.
5, dry the back and mix pulverizing with Chinese medicine grinder.
6, sieve with 120 orders, incapsulate.
7, medication, three times on the one, a 4-6 grain, warm water delivery service, the child reduces by half, 10 days each courses of treatment.
Embodiment 2
1, presses column weight amount proportioning and take by weighing raw material
The Radix Astragali 10 grams, cowherb BUSHICAO 6 grams, Semen Persicae 6 grams, Flos Magnoliae 6 grams, Fructus Xanthii 6 grams, thin 5 grams of stone Chang, Herba Asari 2 grams, Rhizoma Chuanxiong 5 grams, Herba Houttuyniae 3 grams, Radix Platycodonis 5 grams.
The residue preparation process can be with reference to embodiment 1.
Embodiment 3
1, presses column weight amount proportioning and take by weighing raw material
The Radix Astragali 30 grams, cowherb BUSHICAO 15 grams, Semen Persicae 15 grams, Flos Magnoliae 15 grams, Fructus Xanthii 15 grams, thin 10 grams of stone Chang, Herba Asari 6 grams, Rhizoma Chuanxiong 15 grams, Herba Houttuyniae 15 grams, Radix Platycodonis 10 grams.
The residue preparation process can be with reference to embodiment 1.

Claims (3)

1, a kind of medicine for the treatment of sinusitis is characterized in that it is the medicament of being made by the raw material of following weight ratio:
Radix Astragali 10-30 gram cowherb BUSHICAO 6-15 gram Semen Persicae 6-15 gram
The thin 5-10 gram of Flos Magnoliae 6-15 gram Fructus Xanthii 6-15 gram stone Chang
Herba Asari 2-6 gram Rhizoma Chuanxiong 5-15 gram Herba Houttuyniae 3-15 gram Radix Platycodonis 5-10 gram.
2, the medicine of treatment sinusitis according to claim 1, wherein the weight proportion of each raw material is:
Radix Astragali 12-20 gram cowherb BUSHICAO 7-12 gram Semen Persicae 7-12 gram
The thin 7-10 gram of Flos Magnoliae 7-10 gram Fructus Xanthii 7-10 gram stone Chang
Herba Asari 2-4 gram Rhizoma Chuanxiong 7-10 gram Herba Houttuyniae 6-10 gram Radix Platycodonis 6-8 gram.
3, the medicine of treatment sinusitis according to claim 1, wherein the weight proportion of each raw material is:
The Radix Astragali 15 gram cowherb BUSHICAO 10 gram Semen Persicaes 10 grams
Thin 6 grams of Flos Magnoliae 9 gram Fructus Xanthii, 9 gram stone Chang
Herba Asari 3 gram Rhizoma Chuanxiongs 6 gram Herba Houttuyniae 10 gram Radix Platycodoniss 6 grams.
CN 200410012237 2004-04-15 2004-04-15 Medicine for treating nasosinusitis Expired - Fee Related CN1225281C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410012237 CN1225281C (en) 2004-04-15 2004-04-15 Medicine for treating nasosinusitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410012237 CN1225281C (en) 2004-04-15 2004-04-15 Medicine for treating nasosinusitis

Publications (2)

Publication Number Publication Date
CN1562120A true CN1562120A (en) 2005-01-12
CN1225281C CN1225281C (en) 2005-11-02

Family

ID=34477963

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410012237 Expired - Fee Related CN1225281C (en) 2004-04-15 2004-04-15 Medicine for treating nasosinusitis

Country Status (1)

Country Link
CN (1) CN1225281C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614259A (en) * 2011-06-03 2012-08-01 宋协勘 Chinese medicine for treating chronic suppurative nasosinusitis
CN103393971A (en) * 2013-08-06 2013-11-20 秦日香 Traditional Chinese medicine preparation for nursing patients suffering from rhinitis and preparation method thereof
CN103638374A (en) * 2013-11-21 2014-03-19 山东中大药业有限公司 Traditional Chinese medicine composition for treating nasosinusitis of equine animals
CN104523826A (en) * 2015-01-23 2015-04-22 李海红 Medicine for treating nasosinusitis
CN105362820A (en) * 2015-12-19 2016-03-02 许爱美 Medicine for treating chronic nasosinusitis

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614259A (en) * 2011-06-03 2012-08-01 宋协勘 Chinese medicine for treating chronic suppurative nasosinusitis
CN103393971A (en) * 2013-08-06 2013-11-20 秦日香 Traditional Chinese medicine preparation for nursing patients suffering from rhinitis and preparation method thereof
CN103638374A (en) * 2013-11-21 2014-03-19 山东中大药业有限公司 Traditional Chinese medicine composition for treating nasosinusitis of equine animals
CN103638374B (en) * 2013-11-21 2016-05-25 湖南绿亨世源动物药业有限公司 A kind of Chinese medicine composition for the treatment of equus nasosinusitis
CN104523826A (en) * 2015-01-23 2015-04-22 李海红 Medicine for treating nasosinusitis
CN105362820A (en) * 2015-12-19 2016-03-02 许爱美 Medicine for treating chronic nasosinusitis

Also Published As

Publication number Publication date
CN1225281C (en) 2005-11-02

Similar Documents

Publication Publication Date Title
CN101259242B (en) Medicine for treating allergic rhinitis
CN1225281C (en) Medicine for treating nasosinusitis
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN101057942A (en) External applied medicine ointment for treating diabetes foot and its preparing method
CN1324650A (en) Effective medicine for treating cervical vertebra disease as one kind of intractable disease
CN1895593A (en) Medicine for treating acne and its preparation
CN1846781A (en) Medicine for treating chronic pharyngitis
CN1259078C (en) Chinese medicine for treating women's chronic pelvic infection
CN101810749A (en) Chinese medicament for treating urinary tract infection
CN101596297B (en) Tinea-curing pill
CN101181427A (en) Externally used medicament for curing scaly tetter
CN1219527C (en) Ointment for curing acne and its preparation method
CN1939494A (en) Purge capsules for old person and production thereof
CN104587085A (en) Application of saffron traditional Chinese medicine composition to prepare medicaments treating rhinitis
CN1857531A (en) Recipe, preparing process and application of Chinese medicine preparation for treating diabetic retinopathy
CN1257732C (en) Medicine for treating mastosis and preparation process thereof
CN1256970C (en) Naristillae for curing rhinopathy
CN1112200C (en) Chinese-medicinal nose drops for treating acute or chronic rhinitis and its preparing process
CN102430040A (en) Medicament for treating diabetes
CN1682859A (en) Chinese medicine for treating rhinitis
CN100335099C (en) Externally applied pure Chinese medicinal tincture for treating manus and pedes tinea
CN1065137C (en) Liniment made of traditional Chinese medicine for treating pharyngitis, and prepn. method therefor
CN1899478A (en) Chinese medicine composition for treating malignant tumor
CN1839974A (en) Medicine composition for treating rheumatoid disease and method for preparing the same
CN1739540A (en) Application of arctiin in preparing medicine for treating rhinitis and nasosinusitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20051102

Termination date: 20110415